Similar Articles
1321 Primary hepatocellular carcinoma and metabolic syndrome: An update
1322 Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
1323 Epigenetics of hepatocellular carcinoma: Role of microRNA
1324 Proposal of new classification for postoperative patients with hepatocellular carcinoma based on tumor growth characteristics
1325 Imaging appearance of treated hepatocellular carcinoma
1326 Histopathology of type C liver disease for determining hepatocellular carcinoma risk factors
1327 Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis
1328 Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation
1329 Efficacy of capecitabine and oxaliplatin regimen for extrahepatic metastasis of hepatocellular carcinoma following local treatments
1330 Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA